Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 EUR | +2.34% | +1.16% | -4.89% |
2023 | Pangaea Oncology, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Pangaea Oncology, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Sales 2023 * | 10.8M 11.57M 965M | Sales 2024 * | 16.2M 17.36M 1.45B | Capitalization | 50.35M 53.95M 4.5B |
---|---|---|---|---|---|
Net income 2023 * | - 0 0 | Net income 2024 * | - | EV / Sales 2023 * | 4.78 x |
Net Debt 2023 * | 1.3M 1.39M 116M | Net Debt 2024 * | 1.9M 2.04M 170M | EV / Sales 2024 * | 3.23 x |
P/E ratio 2023 * |
-85.5
x | P/E ratio 2024 * |
-
| Employees | 58 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 21.08% |
1 day | +2.34% | ||
1 week | +1.16% | ||
Current month | -5.91% | ||
1 month | -5.91% | ||
3 months | -1.69% | ||
6 months | -15.05% | ||
Current year | -4.89% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 01/07/01 | |
Founder | - | 01/07/01 | |
Founder | - | 01/07/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 01/07/01 | |
Founder | - | 01/07/01 | |
Founder | - | 01/07/01 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 1.75 | +2.34% | 1 000 |
26/24/26 | 1.71 | 0.00% | 0 |
25/24/25 | 1.71 | 0.00% | 2,800 |
24/24/24 | 1.71 | -3.93% | 3,911 |
23/24/23 | 1.78 | +2.89% | 1,384 |
Delayed Quote BME, April 29, 2024 at 03:30 pm IST
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.89% | 53.75M | |
+1.51% | 42.75B | |
+48.43% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- PANG Stock